Tech Company Financing Transactions

HI-Bio Funding Round

HI-Bio, operating out of San Francisco, secured $95 million in funding from Alpha Wave Global, Arch Venture Partners and Arkin Bio-Ventures.

Transaction Overview

Company Name
Announced On
1/4/2024
Transaction Type
Venture Equity
Amount
$95,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance felzartamab, its clinically differentiated lead therapeutic candidate, through clinical readouts in multiple indications and preparation for registrational studies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Tower Place 16th Floor South
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
HI-Bio� was founded on the idea that therapies for immune-mediated diseases (IMDs) have the potential to achieve better results for patients. Many IMDs stem from the dysfunction of cells that make up the immune system, including plasma cells, neutrophils, mast cells and more. These cells are responsible for critical functions and processes.
Profile
HI-Bio LinkedIn Company Profile
Social Media
HI-Bio Company Twitter Account
Company News
HI-Bio News
Facebook
HI-Bio on Facebook
YouTube
HI-Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Travis Murdoch
  Travis Murdoch LinkedIn Profile  Travis Murdoch Twitter Account  Travis Murdoch News  Travis Murdoch on Facebook
Vice President
Donna Flesher
  Donna Flesher LinkedIn Profile  Donna Flesher Twitter Account  Donna Flesher News  Donna Flesher on Facebook
Vice President
Houston Gilbert
  Houston Gilbert LinkedIn Profile  Houston Gilbert Twitter Account  Houston Gilbert News  Houston Gilbert on Facebook
Vice President
Gijsbert Grotenbreg
  Gijsbert Grotenbreg LinkedIn Profile  Gijsbert Grotenbreg Twitter Account  Gijsbert Grotenbreg News  Gijsbert Grotenbreg on Facebook
Vice President
Lara Mangravite
  Lara Mangravite LinkedIn Profile  Lara Mangravite Twitter Account  Lara Mangravite News  Lara Mangravite on Facebook
VP - Bus. Development
Carl Enell
  Carl Enell LinkedIn Profile  Carl Enell Twitter Account  Carl Enell News  Carl Enell on Facebook
VP - Bus. Development
Ariella Kelman
  Ariella Kelman LinkedIn Profile  Ariella Kelman Twitter Account  Ariella Kelman News  Ariella Kelman on Facebook
VP - Finance
Joyce Liaw
  Joyce Liaw LinkedIn Profile  Joyce Liaw Twitter Account  Joyce Liaw News  Joyce Liaw on Facebook
VP - General Counsel
Christina Carlson
  Christina Carlson LinkedIn Profile  Christina Carlson Twitter Account  Christina Carlson News  Christina Carlson on Facebook
VP - Operations
Lorna Dean
  Lorna Dean LinkedIn Profile  Lorna Dean Twitter Account  Lorna Dean News  Lorna Dean on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/4/2024: Annabella-Pump venture capital transaction
Next: 1/4/2024: Nuwa Pen venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary